サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1470349

先進ドラッグデリバリーシステムの世界市場機会と戦略（～2033年）

Advanced Drug Delivery Systems Global Market Opportunities And Strategies To 2033
出版日: | 発行: The Business Research Company | ページ情報: 英文 358 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
先進ドラッグデリバリーシステムの世界市場機会と戦略（～2033年）
出版日: 2024年04月16日
発行: The Business Research Company
ページ情報: 英文 358 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 目次
概要

世界の先進ドラッグデリバリーシステムの市場規模は、2018年に1,922億1,420万米ドルとなり、2023年までCAGR6.0％超で成長しました。

遠隔医療サービスの利用拡大

遠隔医療サービスの利用拡大が、過去期間における先進ドラッグデリバリーシステム市場の成長を支えました。遠隔医療とは、通信機器やデジタルプラットフォームなどの技術を利用して、遠隔地から患者に医療アドバイス、評価、治療、フォローアップを提供するヘルスケアの一種です。ドラッグデリバリーシステムを遠隔医療に取り入れることで、シンプルで効率的なヘルスケアの提供が可能になり、たとえ患者が医療従事者や施設から地理的に離れていても、適切な薬剤、サポート、アドバイスを受けられるようになります。デジタル処方、医療紹介ネットワーク、マイヘルスレコードを担当するオーストラリアの政府機関Australian Digital Health Agencyによると、2020年3月～2022年7月の間に1億1,820万人の遠隔医療治療サービスが1,800万人に提供され、9万5,000人以上の開業医が遠隔医療サービスを利用しています。そのため、遠隔医療サービスの利用拡大が先進ドラッグデリバリーシステム市場の成長を支えました。

目次

第1章 エグゼクティブサマリー

  • 先進ドラッグデリバリーシステム- 市場の魅力とマクロ経済情勢

第2章 目次

第3章 見出し一覧

第4章 図表一覧

第5章 レポートの構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • 先進ドラッグデリバリーシステム市場の定義とセグメンテーション
  • 市場セグメンテーション：タイプ別
    • 経口ドラッグデリバリーシステム
    • 注射式ドラッグデリバリーシステム
    • 吸入/肺ドラッグデリバリーシステム
    • 経皮ドラッグデリバリーシステム
    • 経粘膜ドラッグデリバリーシステム
    • キャリアベースのドラッグデリバリーシステム
    • その他のタイプ
  • 市場セグメンテーション：キャリアタイプ別
    • リポソーム
    • ナノ粒子
    • マイクロスフィア
    • モノクローナル抗体
    • その他のキャリアタイプ
  • 市場セグメンテーション：技術別
    • プロドラッグ
    • インプラントと子宮内避妊器具
    • 標的ドラッグデリバリー
    • ポリマードラッグデリバリー
    • その他の技術
  • 市場セグメンテーション：用途別
    • 腫瘍学
    • 抗感染
    • 中枢神経系
    • 呼吸器疾患
    • 心血管疾患
    • 筋骨格障害
    • 代謝障害
    • その他の用途
  • 市場セグメンテーション：エンドユーザー別
    • 病院
    • 専門クリニック
    • その他のエンドユーザー

第7章 主要な市場動向

  • 高度なドラッグデリバリー技術による前臨床医薬品開発の導入
  • 溶解性マイクロニードルによるドラッグデリバリー方法の焦点の強化
  • 皮下治療のための革新的な体内投与システム
  • 薄膜製剤による先進ドラッグデリバリーの開発
  • 市場におけるイノベーションと拡大を推進するための市場企業間の戦略的パートナーシップとコラボレーション

第8章 先進ドラッグデリバリーシステム市場- マクロ経済シナリオ

  • COVID-19が先進ドラッグデリバリーシステム市場に与える影響
  • ウクライナ戦争が先進ドラッグデリバリーシステム市場に与える影響
  • 高インフレが先進ドラッグデリバリーシステム市場に与える影響

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績（2018年～2023年）
    • 市場促進要因（2018年～2023年）
    • 市場抑制要因（2018年～2023年）
  • 市場成長予測（2023年～2028年、2033年）
    • 市場促進要因（2023年～2028年）
    • 市場抑制要因（2023年～2028年）

第10章 世界の先進ドラッグデリバリーシステム市場セグメンテーション

  • 世界の先進ドラッグデリバリーシステム市場：タイプ別、実績と予測（2018年～2023年、2028年、2033年）
  • 世界の先進ドラッグデリバリーシステム市場：用途別、実績と予測（2018年～2023年、2028年、2033年）
  • 世界の先進ドラッグデリバリーシステム市場：エンドユーザー別、実績と予測（2018年～2023年、2028年、2033年）
  • 世界の先進ドラッグデリバリーシステム市場：キャリアタイプ別、実績と予測（2018年～2023年、2028年、2033年）
  • 世界の先進ドラッグデリバリーシステム市場：技術別、実績と予測（2018年～2023年、2028年、2033年）

第11章 先進ドラッグデリバリーシステム市場：地域および国別分析

  • 世界の先進ドラッグデリバリーシステム市場：地域別、実績と予測（2018年～2023年、2028年、2033年）
  • 世界の先進ドラッグデリバリーシステム市場：国別、実績と予測（2018年～2023年、2028年、2033年）

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Johnson & Johnson
    • 会社概要
    • 製品とサービス
    • ビジネス戦略
    • 財務概要
  • Baxter
    • 会社概要
    • 製品とサービス
    • ビジネス戦略
    • 財務概要
  • Becton, Dickinson and Company
    • 会社概要
    • 製品とサービス
    • ビジネス戦略
    • 財務概要
  • Medtronic Plc
    • 会社概要
    • 製品とサービス
    • ビジネス戦略
    • 財務概要
  • Pacira BioSciences, Inc.
    • 会社概要
    • 製品とサービス
    • 財務概要

第20章 その他の大手企業と革新的企業

  • Abbvie, Inc.
    • 会社概要
    • 製品とサービス
    • ビジネス戦略
  • Gilead Sciences, Inc.
    • 会社概要
    • 製品とサービス
    • ビジネス戦略
  • Merck KGaA
    • 会社概要
    • 製品とサービス
    • ビジネス戦略
  • Danaher Corporation
    • 会社概要
    • 製品とサービス
  • Bausch Health Companies Inc
    • 会社概要
    • 製品とサービス
    • ビジネス戦略
  • Evonik Industries AG
    • 会社概要
    • 製品とサービス
    • ビジネス戦略
  • Ypsomed Holding AG
    • 会社概要
    • 製品とサービス
    • ビジネス戦略
  • SHL Medical AG
    • 会社概要
    • 製品とサービス
    • ビジネス戦略
  • West Pharmaceutical Services, Inc
    • 会社概要
    • 製品とサービス
    • ビジネス戦略
  • Novo Nordisk A/S
    • 会社概要
    • 製品とサービス
    • ビジネス戦略
  • Purdue Pharma LP
    • 会社概要
    • 製品とサービス
  • Luye Pharma Group Ltd.
    • 会社概要
    • 製品とサービス
  • Ipsen Biopharmaceuticals, Inc
    • 会社概要
    • 製品とサービス
    • ビジネス戦略
  • Sun Pharmaceutical Inc
    • 会社概要
    • 製品とサービス
    • ビジネス戦略
  • Takeda Pharmaceutical Company Limited
    • 会社概要
    • 製品とサービス

第21章 競合ベンチマーキング

第22章 競合ダッシュボード

第23章 主要な合併と買収

  • Cordis Corporation Acquired MedAlliance SA
  • DifGen Pharmaceuticals Acquired Aveva Drug Delivery Services Inc
  • LTS Lohmann Therapie-Systeme Acquired Sorrel Wearable Injection Device Business From Eitan Medical
  • SHL Medical Acquired LCA Automation AG
  • Halozyme Therapeutics Inc Acquired Antares Pharma Inc
  • Nemera Acquired Copernicus

第24章 機会と戦略

  • 2028年の世界の先進ドラッグデリバリーシステム市場- 最も新しい機会を提供する国
  • 2028年の世界の先進ドラッグデリバリーシステム市場- 最も新しい機会を提供するセグメント
  • 2028年の世界の先進ドラッグデリバリーシステム市場- 成長戦略
    • 市場動向に基づく戦略
    • 競合戦略

第25章 先進ドラッグデリバリーシステム市場：結論・提言

  • 結論
  • 推奨事項
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第26章 付録

目次
Product Code: o&s1094

Advanced drug delivery systems (ADDS) refer to innovative and sophisticated techniques or technologies designed to enhance the delivery of therapeutic agents (drugs) to specific target sites in the body. ADDS encompass a broad range of approaches, including formulations, carriers and strategies that aim to improve the efficacy, safety and patient compliance of drug delivery.

The advanced drug delivery systems market consists of sales, by entities (organizations, partnerships and sole proprietors), of advanced drug delivery systems that include technologies and methodologies to deliver drugs to specific parts of the body in a controlled manner.

The global advanced drug delivery systems market was valued at $192,214.2 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 6.0%.

Growing Use Of Telemedicine Services

The growing use of telemedicine services supported the growth of the advanced drug delivery systems market during the historic period. Telemedicine is a type of healthcare that involves the use of technology, namely telecommunication equipment and digital platforms, to provide healthcare advice, evaluation, therapy and follow-up to patients remotely. Incorporating drug delivery systems with telemedicine facilitates simple and efficient healthcare delivery, assuring patients receive appropriate drugs, support and advice, even if they are geographically separated from healthcare practitioners or facilities. According to the Australian Digital Health Agency, an Australia-based government organization in charge of digital prescriptions, medical referral networks and My Health Record, 118.2 million telehealth therapy services were offered to 18 million people between March 2020 and July 2022, and more than 95,000 practitioners employ telehealth services. Therefore, the growing use of telemedicine services supported the growth of the advanced drug delivery systems market.

Introducing Preclinical Drug Development With Advanced Drug Delivery Technology

Companies are introducing preclinical drug development with advanced drug delivery technology (EUDRACAP) to accelerate innovation, unlock value and improve quality in the preclinical development stage. This is used to enhance preclinical drug development by offering functional, ready-to-fill oral capsules. These capsules simplify the drug development process, reduce time and variables and safeguard the active ingredient to optimize absorption rates and prevent premature degradation. For example, in October 2023, Evonik, a German-based specialty chemicals company, launched an advanced drug delivery system, called EUDRACAP preclinic enteric, a functional oral capsule designed for use in preclinical trials. This capsule is a very small, 9-h (5.1 mm) technical-grade capsule, suitable for passing through the gastrointestinal tract of preclinical subjects. The capsule simplifies drug development by reducing time, cost and variables and leverages EUDRAGIT(R) functional coatings for optimized release profiles, while offering custom options for specific active pharmaceutical ingredient (API), formulation and brand requirements and a seamless transition from preclinical to clinical and commercial stages, with support for custom capsule coatings, formulation development and current good manufacturing practice (cGMP) scale-up.

The global advanced drug delivery systems market is highly fragmented, with a large number of players operating in the market. The top ten competitors in the market made up to 2.91% of the total market in 2022.

Advanced Drug Delivery Systems Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global advanced drug delivery systems market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies based on local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for advanced drug delivery systems? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The advanced drug delivery systems market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider advanced drug delivery systems market; and compares it with other markets.

The report covers the following chapters:

  • Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by carrier type, by technology, by application and by end user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the advanced drug delivery systems market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by carrier type, by technology, by application and by end user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth - Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Market Opportunities And Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations - This section includes recommendations for advanced drug delivery systems providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:

  • 1) By Type: Oral Drug Delivery System; Injection-Based Drug Delivery System; Inhalation/Pulmonary Drug Delivery System; Transdermal Drug Delivery System; Transmucosal Drug Delivery System; Carrier-Based Drug Delivery System And Other Types
  • 2) By Carrier Type: Liposomes; Nanoparticles; Microspheres; Monoclonal Antibodies; Other Carrier Types
  • 3) By Technology: Prodrug; Implants And Intrauterine Devices; Targeted Drug Delivery; Polymeric Drug Delivery; Other Technologies
  • 4) By Application: Oncology; Anti-Infective; Central Nervous System; Respiratory Diseases; Cardiovascular Diseases; Musculoskeletal Disorders; Metabolic Disorders; Other Applications
  • 5) 4) By End User: Hospitals; Specialized Clinics; Other End Users
  • Companies Mentioned: Johnson & Johnson, Inc; Baxter; Becton, Dickinson And Company; Medtronic Plc; Pacira Biosciences, Inc
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; advanced drug delivery systems indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Advanced Drug Delivery Systems - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Advanced Drug Delivery Systems Market Definition And Segmentations
  • 6.4 Market Segmentation By Type
    • 6.4.1 Oral Drug Delivery System
    • 6.4.2 Injection-Based Drug Delivery System
    • 6.4.3 Inhalation/Pulmonary Drug Delivery System
    • 6.4.4 Transdermal Drug Delivery System
    • 6.4.5 Transmucosal Drug Delivery System
    • 6.4.6 Carrier-Based Drug Delivery System
    • 6.4.7 Other Types
  • 6.5 Market Segmentation By Carrier Type
    • 6.5.1 Liposomes
    • 6.5.2 Nanoparticles
    • 6.5.3 Microspheres
    • 6.5.4 Monoclonal Antibodies
    • 6.5.5 Other Carrier Types
  • 6.6 Market Segmentation By Technology
    • 6.6.1 Prodrug
    • 6.6.2 Implants And Intrauterine Devices
    • 6.6.3 Targeted Drug Delivery
    • 6.6.4 Polymeric Drug Delivery
    • 6.6.5 Other Technologies
  • 6.7 Market Segmentation By Application
    • 6.7.1 Oncology
    • 6.7.2 Anti-Infective
    • 6.7.3 Central Nervous System
    • 6.7.4 Respiratory Diseases
    • 6.7.5 Cardiovascular Diseases
    • 6.7.6 Musculoskeletal Disorders
    • 6.7.7 Metabolic Disorders
    • 6.7.8 Other Application
  • 6.8 Market Segmentation By End User
    • 6.8.1 Hospitals
    • 6.8.2 Specialized Clinics
    • 6.8.3 Other End Users

7 Major Market Trends

  • 7.1 Introducing Preclinical Drug Development With Advanced Drug Delivery Technology
  • 7.2 Increasing Focus Dissolving Microneedle Drug Delivery Methods
  • 7.3 Innovative On-Body Delivery Systems For Subcutaneous Therapies
  • 7.4 Pioneering Advanced Drug Delivery With Thin Film Formulation
  • 7.5 Strategic Partnerships And collaborations Among Market Players To Drive Innovation and Expansion In The Market

8 Advanced Drug Delivery Systems Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The Advanced Drug Delivery Systems Market
  • 8.2 Impact Of The War In Ukraine On The Advanced Drug Delivery Systems Market
  • 8.3 Impact Of High Inflation On The Advanced Drug Delivery Systems Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Advanced Drug Delivery Systems Market Segmentation

  • 10.1 Global Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.4 Global Advanced Drug Delivery Systems Market, Segmentation By Carrier Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.5 Global Advanced Drug Delivery Systems Market, Segmentation By Technology, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Advanced Drug Delivery Systems Market, Regional and Country Analysis

  • 11.1 Global Advanced Drug Delivery Systems Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Advanced Drug Delivery Systems Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Advanced Drug Delivery Systems Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 South Korea Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.1 Western Europe Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.2 Western Europe Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Advanced Drug Delivery Systems Market: Country Analysis
  • 13.5 UK Market
  • 13.6 UK Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.7 UK Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 Germany Market
  • 13.10 Germany Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.11 Germany Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 France Market
  • 13.14 France Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.15 France Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 Italy Market
  • 13.18 Italy Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.19 Italy Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Spain Market
  • 13.22 Spain Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.23 Spain Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Investments
    • 14.1.12 Major Companies
  • 14.2 Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Advanced Drug Delivery Systems Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Advanced Drug Delivery Systems Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Advanced Drug Delivery Systems Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
    • 18.1.1 Market Overview
    • 18.1.2 Region Information
    • 18.1.3 Market Information
    • 18.1.4 Background Information
    • 18.1.5 Government Initiatives
    • 18.1.6 Regulations
    • 18.1.7 Regulatory Bodies
    • 18.1.8 Major Associations
    • 18.1.9 Taxes Levied
    • 18.1.10 Corporate Tax Structure
    • 18.1.11 Investments
    • 18.1.12 Major Companies
  • 18.2 Africa Advanced Drug Delivery Systems Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.3 Africa Advanced Drug Delivery Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Advanced Drug Delivery Systems Market, Segmentation By End User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape and Company Profiles

  • 19.1 Company Profile
  • 19.2 Johnson & Johnson
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial overview
  • 19.3 Baxter
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 Becton, Dickinson and Company
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Medtronic Plc
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Pacira BioSciences, Inc.
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Financial Overview

20 Advanced Drug Delivery Systems Market Other Major And Innovative Companies

  • 20.1 Abbvie, Inc.
    • 20.1.1 Company Overview
    • 20.1.2 Products And Services
    • 20.1.3 Business Strategy
  • 20.2 Gilead Sciences, Inc.
    • 20.2.1 Company Overview
    • 20.2.2 Products And Services
    • 20.2.3 Business Strategy
  • 20.3 Merck KGaA
    • 20.3.1 Company Overview
    • 20.3.2 Products And Services
    • 20.3.3 Business Strategy
  • 20.4 Danaher Corporation
    • 20.4.1 Company Overview
    • 20.4.2 Products And Services
  • 20.5 Bausch Health Companies Inc
    • 20.5.1 Company Overview
    • 20.5.2 Products And Services
    • 20.5.3 Business Strategy
  • 20.6 Evonik Industries AG
    • 20.6.1 Company Overview
    • 20.6.2 Products And Services
    • 20.6.3 Business Strategy
  • 20.7 Ypsomed Holding AG
    • 20.7.1 Company Overview
    • 20.7.2 Products And Services
    • 20.7.3 Business Strategy
  • 20.8 SHL Medical AG
    • 20.8.1 Company Overview
    • 20.8.2 Products And Services
    • 20.8.3 Business Strategy
  • 20.9 West Pharmaceutical Services, Inc
    • 20.9.1 Company Overview
    • 20.9.2 Products And Services
    • 20.9.3 Business Strategy
  • 20.10 Novo Nordisk A/S
    • 20.10.1 Company Overview
    • 20.10.2 Products And Services
    • 20.10.3 Business Strategy
  • 20.11 Purdue Pharma LP
    • 20.11.1 Company Overview
    • 20.11.2 Products And Services
  • 20.12 Luye Pharma Group Ltd.
    • 20.12.1 Company Overview
    • 20.12.2 Products And Services
  • 20.13 Ipsen Biopharmaceuticals, Inc
    • 20.13.1 Company Overview
    • 20.13.2 Products And Services
    • 20.13.3 Business Strategy
  • 20.14 Sun Pharmaceutical Inc
    • 20.14.1 Company Overview
    • 20.14.2 Products And Services
    • 20.14.3 Business Strategy
  • 20.15 Takeda Pharmaceutical Company Limited
    • 20.15.1 Company Overview
    • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

  • 23.1 Cordis Corporation Acquired MedAlliance SA
  • 23.2 DifGen Pharmaceuticals Acquired Aveva Drug Delivery Services Inc
  • 23.3 LTS Lohmann Therapie-Systeme Acquired Sorrel Wearable Injection Device Business From Eitan Medical
  • 23.4 SHL Medical Acquired LCA Automation AG
  • 23.5 Halozyme Therapeutics Inc Acquired Antares Pharma Inc
  • 23.6 Nemera Acquired Copernicus

24 Opportunities And Strategies

  • 24.1 Global Advanced Drug Delivery Systems Market In 2028 - Countries Offering Most New Opportunities
  • 24.2 Global Advanced Drug Delivery Systems Market In 2028 - Segments Offering Most New Opportunities
  • 24.3 Global Advanced Drug Delivery Systems Market In 2028 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Advanced Drug Delivery Systems Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer